CALGARY, Alberta, June 20 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following U.S. Food and Drug Administration (FDA) review, the Company is…

AMSTERDAM, Netherlands, June 19 /PRNewswire/ -- Agendia BV has announced the official opening of the company's new headquarters yesterday at Amsterdam's Science Park at Watergraafsmeer, Kruislaan…

LOS ANGELES, California, June 19 /PRNewswire/ -- Canopus BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy of its oncology candidate, CB1400, as a tumor reducing agent and has also…

KVISTGÅRD, Denmark, June 19 /PRNewswire/ -- Bavarian Nordic's cancer research unit, BN ImmunoTherapeutics, has completed an interim analysis of its first two clinical studies with MVA-BN(R)-HER2, a…

Radiation is dangerous. In high doses it is certainly lethal and chronic exposure is linked to the development of cancer. That's why we have bomb shelters and canned food. But what if a short-term…

Patients diagnosed with colon cancer who had abundant vitamin D in their blood were less likely to die during a follow-up period than those who were deficient in the vitamin, according to a new study…

SAN DIEGO, California, June 18 /PRNewswire/ -- Germany is on the cutting edge in biotechnology R&D and is a top player in large- and clinical-scale production. Companies located in Germany are…

GENEVA, June 18 /PRNewswire/ -- - Bionomics and Merck Serono to Collaborate to Discover and Develop Novel, Oral Treatment for MS - Collaboration Based on Novel Compounds That Allow Selective…

LOS ANGELES, California, June 18 /PRNewswire/ -- Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from…

SAN DIEGO, June 18 /PRNewswire/ -- - Potent Adjuvant is a Toll-Like Receptor 3 (TLR3) Agonist Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company has developed a…